Chemoinformaics analysis of dihydroartemisic acid
| Molecular Weight | 236.355 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 12 |
| Exact Molecular Weight | 236.178 | nRing | 2 |
| Solubility: LogS | -3.365 | nHRing | 0 |
| Solubility: LogP | 4.88 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 42.657 |
| nHD | 1 | BPOL | 24.945 |
| QED | 0.742 |
| Synth | 4.08 |
| Natural Product Likeliness | 2.414 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.025 |
| CACO-2 | -4.59 |
| MDCK | 0.0000165 |
| BBB | 0.292 |
| PPB | 0.970626 |
| VDSS | 0.558 |
| FU | 0.0279604 |
| CYP1A2-inh | 0.149 |
| CYP1A2-sub | 0.64 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.892 |
| CYP2c9-inh | 0.082 |
| CYP2c9-sub | 0.895 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.143 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.213 |
| CL | 3.45 |
| T12 | 0.772 |
| hERG | 0.018 |
| Ames | 0.005 |
| ROA | 0.173 |
| SkinSen | 0.343 |
| Carcinogencity | 0.531 |
| EI | 0.455 |
| Respiratory | 0.925 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.932559 |